[1. Aminnezhad S, Kasra-Kermanshahi R (2014) Antibiofilm activity of cell-free supernatant from Lactobacillus casei in Pseudomonas aeruginosa. Feyz 18:30–7.]Search in Google Scholar
[2. Andersen TE, Khandige S, Madelung M, Brewer J, Kolmos HJ, Møller-Jensen J (2012) Escherichia coli uropathogenesis in vitro: invasion, cellular escape, and secondary infection analyzed in a human bladder cell infection model. Infect and Immun 80(5): 1858–67.10.1128/IAI.06075-11334743322354025]Search in Google Scholar
[3. Axe DD, Bailey JE (1995) Transport of lactate and acetate through the cytoplasmic membrane of Escherichia coli. Biotechnol Bioeng 47:8–19.10.1002/bit.26047010318623362]Search in Google Scholar
[4. Balaban N, Cirioni O, Giacometti A, Ghiselli R, Braunstein JB, Silvestri C, Mocchegiani F, Saba V, Scalise G (2007) Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP. Antimicrob Agents Chemother 51:2226–9.10.1128/AAC.01097-06189138317371825]Search in Google Scholar
[5. Barken KB, Pamp SJ, Yang L, Gjermansen M, Bertrand JJ, Klausen M, Givskov M, Whitchurch CB, Engel JN, Tolker-Nielsen T (2008) Roles of type IV pili, flagellum-mediated motility and extracellular DNA in the formation of mature multicellular structures in Pseudomonas aeruginosa biofilms. Environ Microbiol 10:2331–43.10.1111/j.1462-2920.2008.01658.x18485000]Search in Google Scholar
[6. Bassler BL, Losick R (2006) “Bacterially speaking,” Cell 125(2):237–246.10.1016/j.cell.2006.04.00116630813]Search in Google Scholar
[7. Beerepoot M, Ter Riet G, Nys S, van der Wal WM, De Borgie CA, de Reijke TM (2012) Lactobacilli versus antibiotics to prevent urinary tract infections. A randomized double-blind non-inferiority trial in postmenopausal women. Arch Intern Med 172(9):704–712.]Search in Google Scholar
[8. Behnsen J, Deriu E, Sassone-Corsi M, Raffatellu M (2013) Probiotics: properties, examples, and specific applications. Cold Spring Harb Perspect Med 3:1–15.10.1101/cshperspect.a010074357920623457295]Search in Google Scholar
[9. Bower JM, Eto DS, Mulvey MA (2005) Covert operations of uropathogenic Escherichia coli within the urinary tract Traffic 6:18–31.10.1111/j.1600-0854.2004.00251.x252325915569242]Search in Google Scholar
[10. Cadieux PA1, Burton J, Devillard E, Reid G (2009) Lactobacillus by-products inhibit the growth and virulence of uropathogenic Escherichia coli. J Physiol Pharmacol 60 (Suppl 6):13–18.]Search in Google Scholar
[11. Christensen GD, Simpson WA, Younger JJ, Baddour LM, Barrett FF, Melton DM, Beachey EH (1985) Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 22:996–1006.10.1128/jcm.22.6.996-1006.19852718663905855]Search in Google Scholar
[12. Delley M, Bruttin A, Richard M, Affolter M, Rezzonico E, Brück WM (2015) In vitro activity of commercial probiotic Lactobacillus strains against uropathogenic Escherichia coli. FEMS Microbiology Lett 362(13).10.1093/femsle/fnv09626078118]Search in Google Scholar
[13. Diez-Gonzalez F, Russell JB (1997) The ability of Escherichia coli O157:H7 to decrease its intracellular pH and resist the toxicity of acetic acid. Microbiol 143:1175–118010.1099/00221287-143-4-11759141680]Search in Google Scholar
[14. Freestone P (2013) Communication between bacteria and their hosts. Scientifica 2013:1–1510.1155/2013/361073387190624381789]Search in Google Scholar
[15. Geerlings SE, Beerepoot MA, Prins JM (2014) Prevention of recurrent urinary tract infections in women: antimicrobial and nonantimicrobial strategies. Infect Dis Clin, 28(1):135–147.10.1016/j.idc.2013.10.00124484580]Search in Google Scholar
[16. Guandalini S (2011) Probiotics for prevention and treatment of diarrhea. J Clin Gastroenterol 45:149–153.10.1097/MCG.0b013e3182257e9821992955]Search in Google Scholar
[17. Guarino A, Vecchio AL, Canani RB (2009) Probiotics as prevention and treatment for diarrhea. Curr Opin Gastroenterol 25(1):18–23.10.1097/MOG.0b013e32831b445519114770]Search in Google Scholar
[18. Hacker J, Blum-Oehler G, Janke B, Nagy G, Goebel W (1999) Pathogenicity Islands of Extraintestinal Escherichia coli. In Kaper JB, Hacker J (eds) Pathogenicity Islands and Other Mobile Virulence Elements. Washington DC: ASM Press 59–76.10.1128/9781555818173.ch4]Search in Google Scholar
[19. Hagan EC, Mobley HLT (2007) Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection. Infect Immun 75:3941–9.10.1128/IAI.00337-07195197217517861]Search in Google Scholar
[20. Hunstad DA, Justice SS (2010) Intracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli. Annu Rev Microbiol 64:203–221.10.1146/annurev.micro.112408.13425820825346]Search in Google Scholar
[21. Karska-Wysocki B, Bazo M, Smoragiewicz W (2010) Antibacterial activity of Lactobacillus acidophilus and Lactobacillus casei against methicillin-resistant Staphylococcus aureus (MRSA). Microbiol Res 165(8):674–686.10.1016/j.micres.2009.11.00820116228]Search in Google Scholar
[22. Kim Y, Kim SH (2009) Released exopolysaccharide (r-EPS) produced from probiotic bacteria reduce biofilm formation of enterohemorrhagic Escherichia coli O157: H7. Biochem Biophys Res Commun 379:324–9.10.1016/j.bbrc.2008.12.05319103165]Search in Google Scholar
[23. Kulkarni R, Dhakal BK, Slechta ES, Kurtz Z, Mulvey MA, Thanassi DG (2009) Roles of putative type II secretion and type IV pilus systems in the virulence of uropathogenic Escherichia coli. PLoS One 4(3).10.1371/journal.pone.0004752264943119270734]Search in Google Scholar
[24. Kulkarni R, Dhakal BK, Slechta ES, Kurtz Z, Mulvey MA, Thaassi DG (2009) Roles of putative type II secretion and type IV pilus systems in the virulence of uropathogenic Escherichia coli. PLoS ONE 4:1–9.10.1371/journal.pone.0004752]Search in Google Scholar
[25. Lash BW, Mysliwiec TH, Gourama H, Mysliwiec TH (2005) Detection and partial characterization of a broad-range bacteriocin produced by Lactobacillus plantarum (ATCC 8014). Food Microbiol 22:199–204.10.1016/j.fm.2004.03.006]Search in Google Scholar
[26. Lee JH, Subhadra B, Son YJ, Kim DH, Park HS, Kim JM, Koo SH, Oh MH, Kim HJ, Choi CH (2016) Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea. Lett App Microbiol 62(1):84–90.10.1111/lam.12517]Search in Google Scholar
[27. Li D, Liu B, Chen M, Guo D, Guo X, Liu F, Feng L, Wang L (2010) A multiplex PCR method to detect 14 Escherichia coli serogroups associated with urinary tract infections. J Microbiol Methods 82:71–7.10.1016/j.mimet.2010.04.008]Search in Google Scholar
[28. Makino S, Ikegami S, Kano H, Sashihara T, Sugano H, Horiuchi H, Saito T, Oda M (2006) Immunomodulatory effects of polysaccharides produced by Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. J Dairy Sci 89:2873–81.10.3168/jds.S0022-0302(06)72560-7]Search in Google Scholar
[29. Mandal P, Kapil A, Goswami K, Das B, Dwivedi SN (2001) Uropathogenic Escherichia coli causing urinary tract infections. Indian J Med Res 114:207–11.]Search in Google Scholar
[30. Martín R, Suárez JE (2010) Biosynthesis and degradation of H2O2 by vaginal lactobacilli. Appl Environ Microbiol 76:400–405.10.1128/AEM.01631-09280522819948869]Search in Google Scholar
[31. Miyazaki J, Ba-Thein W, Kumao T, Obata Yasuoka M, Akaza H, Hayshi H (2002) Type 1, P and S fimbriae, and afimbrial adhesin I are not essential for uropathogenic Escherichia coli to adhere to and invade bladder epithelial cells. FEMS Immunol Med Microbiol 25:23–6.10.1111/j.1574-695X.2002.tb00567.x11985964]Search in Google Scholar
[32. Miyazaki Y, Yokota H, Takahashi H, Fukuda M, Kawakami H, Kamiya S, Hanawa T (2010) Effect of probiotic bacterial strains of Lactobacillus, Bifidobacterium, and Enterococcus on enteroaggregative Escherichia coli. J Infect Chemother 16(1):10–18.10.1007/s10156-009-0007-220054601]Search in Google Scholar
[33. Morais MBD, Jacob CMA (2006) The role of probiotics and prebiotics in pediatric practice. J de Pediat 82(5):189–97.]Search in Google Scholar
[34. Morelli L, Zonenenschain D, Del Piano M, Cognein P (2004) Utilization of the intestinal tract as a delivery system for urogenital probiotics. J Clin Gastroenterol 38:107–110.10.1097/01.mcg.0000128938.32835.9815220672]Search in Google Scholar
[35. Nader-Macías MEF, Silva de Ruiz C, Ocaña VS, Juárez Tomás MS (2008) Advances in the knowledge and clinical applications of lactic acid bacteria as probiotics in the urogenital tract. Curr Women’s Health Rev 4:240–257.10.2174/157340408786848214]Search in Google Scholar
[36. Nigam A, Kumar A, Madhusuda HV, Bhola N (2012) In-vitro Screening of antibacterial activity of lactic acid bacteria against common enteric pathogens Astha Nigam, Madhusudan HV, and Neelam Bhola Departmaent of Microbiology, CloneGen Biotechnology Ltd. J Biomed Sci 4(2):1–5.]Search in Google Scholar
[37. Ocana VS, Bru E, de Ruiz Holgado AA Nader-Macıas ME (1999) Surface characteristics of lactobacilli isolated from human vagina. J Gen Appl Microbiol 45:203–212.10.2323/jgam.45.203]Search in Google Scholar
[38. Ogawa M, Shimizu K, Nomoto K, Tanaka R, Hamabata T, Yamasaki S, Takeda T, Takeda Y (2001) Inhibition of in vitro growth of Shiga toxin-producing Escherichia coli O157:H7 by probiotic bacteria Lactobacillus strains due to production of latic acid. Int J Food Microbiol 68:135–140.10.1016/S0168-1605(01)00465-2]Search in Google Scholar
[39. Poppi LB, Rivaldi JD, CoutinhoTS, Astolfi-Ferreira CS, Ferreira AJP, Mancilha IM (2015) Effect of Lactobacillus sp. isolates supernatant on Escherichia coli O157: H7 enhances the role of organic acids production as a factor for pathogen control. Pesquisa Veterinária Brasileira 35(4):353–359.]Search in Google Scholar
[40. Ruiz J, Simon K, Horcajada JP, Velasco M, Barranco M, Roig G, Moreno-Martínez A, Martínez JA, Jiménez de Anta T, Mensa J, Vila J (2002) Differences in virulence factors among clinical isolates of Escherichia coli causing cystitis and pyelonephritis in women and prostatitis in men. J of Clin Microbiol 40:12:4445–49.10.1128/JCM.40.12.4445-4449.2002]Search in Google Scholar
[41. Saavedra J (2000) Probiotics and infectious diarrhea. Am J Gastroenterol 95(1) :16–18.10.1016/S0002-9270(99)00811-4]Search in Google Scholar
[42. Sabaté M, Moreno E, Pérez T, Andreu A, Prats G (2006) Pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates. Clin Microbiol Infect 12:88010.1111/j.1469-0691.2006.01461.x16882293]Search in Google Scholar
[43. Sadri M, Arab Soleimani N, Forghanifard MM (2016) The study of Antimicrobial and Anti-adhesive effect of Probiotic Lactobacilli on Uropathogenic Escherichia coli (UPEC). Biol J Microorganism 5:159–70.]Search in Google Scholar
[44. Segarra-Newnham M (2007) Probiotics for Clostridium difficile–associated diarrhea: focus on Lactobacillus rhamnosus GG and Saccharomyces boulardii. Ann Pharmacother 41(7-8):1212-21.10.1345/aph.1K11017595306]Search in Google Scholar
[45. Servin AL (2004) Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev 28(4):405–440.10.1016/j.femsre.2004.01.00315374659]Search in Google Scholar
[46. Sivick K E, Mobley H L (2010) Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun 78(2):568–585.]Search in Google Scholar
[47. Stoyancheva G, Marzotto M, Dellaglio F, Torriani S (2014) Bacteriocin production and gene sequencing analysis from vaginal Lactobacillus strains. Arch Microbiol 196:645–65310.1007/s00203-014-1003-124919535]Search in Google Scholar
[48. Terraf MCL, Tomás MSJ, Rault L, Le Loir Y, Even S, Nader-Macías MEF (2017) In vitro effect of vaginal lactobacilli on the growth and adhesion abilities of uropathogenic Escherichia coli. Arch Microbiol 199(5):767–774.10.1007/s00203-016-1336-z28280842]Search in Google Scholar
[49. Tomas J MS, Ocaña VS, Wiese B, Nader-Macías ME (2003) Growth and lactic acid production by vaginal Lactobacillus acidophilus CRL 1259, and inhibition of uropathogenic Escherichia coli. J Med Microbiol 52(12):1117-1124.10.1099/jmm.0.05155-014614071]Search in Google Scholar
[50. Tomás J MS, Saralegui Duhart CI, De Gregorio PR, Vera Pingitore E, Nader-Macías ME (2011) Urogenital pathogen inhibition and compatibility between vaginal Lactobacillus strains to be considered as probiotic candidates. Eur J Obstet Gynecol Reprod Biol 159:399–406.10.1016/j.ejogrb.2011.07.01021862199]Search in Google Scholar
[51. Turroni F, Ventura M, Butto LF. et al. (2014) Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective. Cell Mol Life Sci 71:183–203.10.1007/s00018-013-1318-023516017]Search in Google Scholar
[52. Uzun C, Oncül O, Gümüş D, Alan S, Dayioğlu N, Küçüker MA (2015) Virulence genes and antibiotic susceptibilities of uropathogenic E. coli strains. Clin Lab 61(8):941-950.]Search in Google Scholar
[53. Vacheva A, Georgieva R, Danova S, Mihova R, Marhova M, Kostadinova S, Stoitsova S (2012) Modulation of Escherichia coli biofilm growth by cell-free spent cultures from lactobacilli. Open Life Sci 7(2):219-229.10.2478/s11535-012-0004-9]Search in Google Scholar
[54. Wagner RD, Johnson SJ (2012) Probiotic lactobacillus and estrogen effects on vaginal epithelial gene expression responses to Candida albicans. J Biomed Sci 19(1):58.]Search in Google Scholar
[55. Wang J, Zhao X, Yang Y, Zhao A, Yang Z (2015) Characterization and bioactivities of an exopolysaccharide produced by Lactobacillus plantarum YW32. Int J Biol Macromol 74:119-26.10.1016/j.ijbiomac.2014.12.00625532782]Search in Google Scholar
[56. Waters CM, Bassler BL (2005) “Quorum sensing: cell-to-cell communication in bacteria”. Annu Rev Cell Dev Biol 21:319–346.10.1146/annurev.cellbio.21.012704.13100116212498]Search in Google Scholar
[57. Wu CC, Lin CT, Wu CY, Peng WS, Lee MJ, Tsai YC (2015) Inhibitory effect of Lactobacillus salivarius on Streptococcus mutans biofilm formation. Mol Oral Microbiol 30(1):16–26.]Search in Google Scholar
[58. Yamamoto S (2007) Molecular epidemiology of Escherichia coli. J Infect Chemother 13:68–73.10.1007/s10156-007-0506-Y17458672]Search in Google Scholar
[59. Zamani H, Rahbar S, Garakoui SR, Afsah Sahebi A, Jafari H (2017) Antibiofilm potential of Lactobacillus plantarum spp. cell free supernatant (CFS) against multidrug resistant bacterial pathogens. Pharma Biomed Res 3(2):39–44.]Search in Google Scholar
[60. ***FAO/WHO (2001). Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. Cordoba, Argentina: WHO.]Search in Google Scholar